| 文拉法辛缓释胶囊与西酞普兰片治疗脑卒中后抑郁患者的对照研究 |
| 投稿时间：2013-11-14 修订日期：2014-03-31 点此下载全文 |
| 引用本文：夏时炎,沈壮宏,张颖然,张鹏.文拉法辛缓释胶囊与西酞普兰片治疗脑卒中后抑郁患者的对照研究[J].药学实践杂志,2015,33(2):173~175 |
| 摘要点击次数: 1203 |
| 全文下载次数: 346 |
|
|
| 中文摘要:目的 比较文拉法辛缓释胶囊与西肽普兰片治疗脑卒中后抑郁的疗效及安全性。 方法 将60例脑卒中后抑郁患者随机分为文拉法辛缓释胶囊(n=30)和西酞普兰片组(n=30),治疗8周,采用汉密顿抑郁量表(Hamilton rating scale for depression,HAMD)和不良反应量表(treatment emergent system scale,TESS)评定疗效及不良反应。 结果 治疗4~8周后两组患者HAMD评分均较治疗前显著降低(P<0.05),但两组间差异无统计学意义(P>0.05),文拉法辛组在2周末时HAMD评分较西肽普兰组有显著差异(P<0.05)。不良反应发生率及严重程度两组差异均无统计学意义(P>0.05)。 结论 两组总体疗效和不良反应均相近,文拉法辛起效较西酞普兰快。 |
| 中文关键词:卒中后抑郁症 文拉法辛 西酞普兰 |
| |
| Comparative study of venlafaxine sustained-release capsules and citalopram tablet in the treatment of post-stroke depression |
|
|
| Abstract:Objective To compare the therapeutic effectiveness and safeness of venlafaxine sustained-release capsules and citalopram tablets in the treatment of post-stroke depression. Methods 60 patients were randomly divided into venlafaxine group (n=30)and citalomram group(n=30) for 8 weeks treatment. Hamilton rating scale for depression(HAMD) and treatment emergent system scale (TESS) were used to evaluate the efficacy and side effects, respectively. Results After 4-8 weeks of treatment,both scores of HAMD of the two groups decreased significantly(P<0.05),but there was no difference between the two groups(P>0.05). The total scores of HAMD in venlafaxine group were notably lower than citalopram group after 2 weeks(P<0.05). There was no significant difference in side effects between the two groups(P>0.05). Conclusion There was no significant difference in gross curative effect and side effects between two groups; venlafaxine worked faster compared to citalopram. |
| keywords:post-stroke depression venlafaxine citalopram |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
